The role of the CAG repeat androgen receptor polymorphism in andrology

Frontiers of Hormone Research

Volumn 37, Issue , 2009, Pages 52-61

  Zitzmann, Michael ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; AR PROTEIN, HUMAN; TESTOSTERONE; UNCLASSIFIED DRUG;

ANDROGEN INSENSITIVITY SYNDROME; ANDROGEN RECEPTOR GENE; ANDROGEN THERAPY; ANDROLOGY; BONE TISSUE; EXON; GENE; GENE SEQUENCE; HUMAN; HYPOGONADISM; KARYOTYPING; KENNEDY DISEASE; KLINEFELTER SYNDROME; PHARMACOGENETICS; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PSYCHOLOGICAL ASPECT; REPRODUCTION; RETROSPECTIVE STUDY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPERMATOGENESIS; TARGET ORGAN; ANIMAL; BONE DENSITY; GENETICS; MALE; MOUSE; PHYSIOLOGY; PROSTATE TUMOR; TRINUCLEOTIDE REPEAT;

ANIMALS; BONE DENSITY; BULBO-SPINAL ATROPHY, X-LINKED; HUMANS; HYPOGONADISM; MALE; MICE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TESTOSTERONE; TRINUCLEOTIDE REPEATS;

EID: 59849123606     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000175843     Document Type: Review

References (47)

1. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS: Androgen receptor defects: historical, clinical, and molecular perspectives. End -ocr Rev 1995;16:271-321.
2. Hiort O, Sinnecker GHG, Holterhus PM, Nitsche EM, Kruse K: The clinical and molecular spectrum of androgen insensitivity. Am J Med Genet 1996; 63:218-222.
3. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH: Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77-79.
4. Hsiao P W, Thin TH, Lin DL, Chang C: Differential regulation of testosterone vs. 5alpha-dihydrotestosterone by selective androgen response elements. Mol Cell Biochem 2000;206:169-175.
5. Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, Coetzee GA: Inhibition of p160-mediated coactiva-tion with increasing androgen receptor polygluta-mine length. Hum Mol Genet 2002;9:267-274.
6. Holterhus PM, Hiort O, Demeter J, Brown PO, Brooks JD: Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the andro-gen receptor. Genome Biol 2003;4:R37.
7. Chang C, Kokontis J, Liao S: Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 1988;85:7211-7215.
8. Chang C, Kokontis J, Liao S: Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 1988;240:324-326.
9. Lubahn DB, Joseph DR, Sar M, Tan J-A, Higgs HN, Larson RE, French FS, Wilson EM: The human andr -ogen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 1988;2:1265-1275.
10. Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM: Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 1988;240:327-330.
11. Tilley WD, Marcelli M, Wilson JD, McPhaul MJ: Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci USA 1989;86:327-331.
12. Trapman J, Klaassen P, Kuiper GGJM, van der Kor-put JAGM, Faber P W, van Rooij HCJ, Geurts van Kessel A, Voorhorst MM, Mulder E, Brinkmann AO: Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun 1988;153:241-248.
13. Hellwinkel OJ, Bull K, Holterhus PM, Homburg N, Struve D, Hiort O: Complete androgen insensitivity caused by a splice donor site mutation in intron 2 of the human androgen receptor gene resulting in an exon 2-lacking transcript with premature stop-codon and reduced expression. J Steroid Biochem Mol Biol 1999;68:1-9.
14. Hellwinkel OJC, Holterhus PM, Struve D, Homburg N, Hiort O: A unique exonic splicing mutation in the human androgen receptor gene demonstrates the physiologic relevance of regular androgen receptor transcript variants. J Clin Endocrinol Metab 2001; 86:2569-2575.
15. Albertelli MA, Scheller A, Brogley M, Robins DM: Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol 2006;20:1248-1260.
16. Coutinho-Camillo CM, Miracca EC, dos Santos ML, Salaorni S, Sarkis AS, Nagai MA: Identification of differentially expressed genes in prostatic epithelium in relation to androgen receptor CAG repeat length. Int J Biol Markers 2006;21:96-105.
17. Kennedy WR, Alter M, Sung JH: Progressive proximal spinal and bulbar muscular atrophy of late onset. Neurology 1968;18:671-680.
18. Arbizu T, Santamaria J, Gomez JM, Quilez A, Serra JP: A family with adult onset spinal and bulbar muscular atrophy X-linked inheritance and associated testicular failure. J Neurol Sci 1983;59:371-382.
19. Dejager S, Bry-Gauillard H, Bruckert E, Eymard B, Salachas F, LeGuern E, Tardieu S, Chadarevian R, Giral P, Turpin G: A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J Clin Endocrinol Metab 2002;87:3893-3901.
20. Suzuki K, Katsuno M, Banno H, Takeuchi Y, Atsuta N, Ito M, Watanabe H, Yamashita F, Hori N, Nakamura T, Hirayama M, Tanaka F, Sobue G: CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain 2008;131: 229-239.
21. Abdullah A, Trifiro MA, Panet-Raymond V, Alva -ra do C, de Tourreil S, Frankel D, Schipper HM, Pinsky L: Spinobulbar muscular atrophy: poly-glutamine-expanded androgen receptor is prote-olytically resistant in vitro and processed abnor mally in transfected cells. Hum Mol Genet 1998;7:379-384.
22. Zeegers M P, Kiemeney LA, Nieder AM, Ostrer H: How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiol Biomarkers Prev 2004;13:1765-1771.
23. Giwercman C, Giwercman A, Pedersen HS, Toft G, Lundin K, Bonde JP, Lundberg GY: Polymorphisms in genes regulating androgen activity among prostate cancer low-risk Inuit men and high-risk Scandi -navians. Int J Androl 2008;31:25-30.
24. Giovannucci E, Stampfer MJ, Chan A, Krithivas K, Gann PH, Hennekens CH, Kantoff PW: CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians. Prostate 1999;39:130-134.
25. Giovannucci E, Platz EA, Stampfer MJ, Chan A, Krithivas K, Kawachi I, Willett WC, Kantoff PW: The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology 1999;53: 121-125.
26. Mitsumori K, Terai A, Oka H, Segawa T, Ogura K, Yoshida O, Ogawa O: Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth. Prostate 1999;41:253-257.
27. Larré S, Hamadeh H, Azzouzi AR, Vallancien G, Cochand-Priollet B, Cancel-Tassin G, Cussenot O: Genetic impact on prostate anatomical variability during ageing: role of CYP17, SRD5A2 and andro-gen receptor genes polymorphisms. BJU Int 2007; 100:679-684.
28. Davis-Dao CA, Tuazon ED, Sokol RZ, Cortessis VK: Male infertility and variation in CAG repeat length in the androgen receptor gene: a meta-analy-sis. J Clin Endocrinol Metab 2007;92:4319-4326.
29. Zitzmann M, Brune M, Kornmann B, Gromoll J, Junker R, Nieschlag E: The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocrinol 2001;55:649-657.
30. Zmuda JM, Cauley JA, Kuller LH, Newman AB, Robbins J, Harris T, Ferrell RE: Androgen receptor CAG repeat polymorphism: a novel marker of osteo-porotic risk in men. Osteoporosis Int 2000;11:S151.
31. Zmuda JM, Cauley JA, Kuller LH, Zhang X, Palermo L, Nevitt MC, Ferrell RE: Androgen receptor CAG repeat length is associated with increased hip bone loss and vertebral fracture risk among older men. J Bone Miner Res 2000;15:S491, M141.
32. Remes T, Vaisanen SB, Mahonen A, Huuskonen J, Kroger H, Jurvelin JS, Penttila IM, Rauramaa R: Aerobic exercise and bone mineral density in middle-aged Finnish men: a controlled randomized trial with reference to androgen receptor aromatase and estrogen receptor alpha gene polymorphisms. Bone 2003;32:412-420.
33. Langdahl BL, Stenkjaer L, Carstens M, Tofteng CL, Eriksen EF: A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures. Calcif Tissue Int 2003;73:237-243.
34. Burris AS, Banks SM, Carter CS, Davidson JM, Sherins RJ: A long-term prospective study of the physiologic and behavioural effects of hormone replacement in untreated hypogonadal men. J Androl 1992;13:297-304.
35. Pope HG, Cohane GH, Kanayama G, Siegel AJ, Hudson JI: Testosterone Gel supplementation for men with refractory depression: a randomized placebo-controlled trial. Am J Psychiatry 2003;160: 105-111.
36. Seidman SN, Araujo AB, Roose SP, McKinlay JB: Testosterone level androgen receptor polymorphism and depressive symptoms in middle-aged men. Biol Psychol 2001;50:371-376.
37. Harkonen K, Huhtaniemi I, Makinen J, Hübler D, Irjala K, Koskenvuo M, Oettel M, Raitakari O, Saad F, Pollanen P: The polymorphic androgen receptor gene CAG repeat pituitary-testicular function and andropausal symptoms in ageing men. Int J Androl 2003;26:187-194.
38. Colangelo LA, Sharp L, Kopp P, Scholtens D, Chiu BC, Liu K, Gapstur SM: Total testosterone, androgen receptor polymorphism, and depressive symptoms in young black and white men: the CARDIA Male Hormone Study. Psychoneuroendocrinology 2007;32:951-958.
39. Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E: X-chromosome inactivation patterns and andro-gen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J Clin Endocrinol Metab 2004;89:6208-6217.
40. Zinn AR, Ramos P, Elder FF, Kowal K, Samango-Sprouse C, Ross JL: Androgen receptor CAGn repeat length influences phenotype of 47,XXY (Klinefelter) syndrome. J Clin Endocrinol Metab 2005;90:5041-5046.
41. Wikstrom AM, Painter JN, Raivio T, Aittomaki K, Dunkel L: Genetic features of the X chromosome affect pubertal development and testicular degeneration in adolescent boys with Klinefelter syndrome. Clin Endocrinol (Oxf) 2006;65:92-97.
42. Vorona E, Zitzmann M, Gromoll J, Schüring AN, Nieschlag E: Clinical, endocrinological, and epige-netic features of the 46,XX male syndrome, compared with 47,XXY Klinefelter patients. J Clin Endocrinol Metab 2007;92:3458-3465.
43. Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E: Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study. J Clin Endocrinol Metab 2003;88:2049-2054.
44. Zitzmann M, Nieschlag E: Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metab 2007;92:3844-3853.
45. Von Eckardstein S, Schmidt A, Kamischke A, Simoni M, Gromoll J, Nieschlag E: CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception. Clin Endocrinol 2002;57: 647-655.
46. Wakisaka N, Taira Y, Ishikawa M, Nakamizo Y, Kobayashi K, Uwabu M, Fukuda Y, Taguchi Y, Hama T, Kawakami M: Effectiveness of finasteride on patients with male pattern baldness who have different androgen receptor gene polymorphism. J Investig Dermatol Symp Proc 2005;10:293-294.
47. Retornaz F, Paris F, Lumbroso S, Audran F, Tigoulet F, Michelon C, Jeandel C, Sultan C, Blain H: Association between androgen receptor gene polymorphism and bone density in older women using hormone replacement therapy. Maturitas 2006;55: 325-333.